2型糖尿病起始胰岛素后方案转换的临床指导建议

被引：23

作者：

朱大龙

机构：

[1] 《型糖尿病起始胰岛素后方案转换的临床指导建议》编写委员会

[2] 南京大学医学院附属鼓楼医院

来源：

中华糖尿病杂志 | 2018年 / 10卷 / 02期

关键词：

D O I：

暂无

中图分类号：

+ [];

学科分类号：

摘要：

<正>2型糖尿病(T2DM)的治疗是一个长期的过程。新诊断患者大多可在生活方式干预的基础上,起始口服降糖药物(oral antidiabetic agents,OADs)治疗;如有显著临床症状且血糖明显升高,则可给予短期胰岛素强化治疗。新诊断患者给予胰岛素强化治疗解除高糖毒性后,胰岛β细胞功能可能部分恢复,再根据患者病情给予个体化治疗方案。开始OADs治疗后,随着病程进展,部分患者

引用

收藏

相关论文

共 15 条

[1]

2型糖尿病短期胰岛素强化治疗临床专家指导意见 [J].

李延兵 ;

马建华 ;

母义明 .

药品评价, 2017, 14 (09) :5-12+26

[2]

双时相门冬胰岛素50与人胰岛素50的疗效和安全性比较：一项随机交叉试验 [J].

郭晓蕙 ;

边芳 ;

董玉梅 ;

唐红 ;

田坚 ;

王桂侠 ;

杨涛 ;

李玉凤 ;

周迎生 ;

朱大龙 ;

黄珊 ;

林静 ;

赵湜 ;

王坚 ;

葛蕾 ;

渠翊 ;

高妍 .

中华内分泌代谢杂志, 2016, 32 (07)

[3]

中国胰岛素泵治疗指南(2014版)节选(上).[J]..糖尿病天地(临床).2014, 08

[4]

Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial [J].

Jin, Sang-Man ;

Kim, Jae Hyeon ;

Min, Kyung Wan ;

Lee, Ji Hyun ;

Ahn, Kue Jeong ;

Park, Jeong Hyun ;

Jang, Hak Chul ;

Park, Seok Won ;

Lee, Kwan Woo ;

Won, Kyu Chang ;

Kim, Young-Il ;

Chung, Choon Hee ;

Park, Tae Sun ;

Lee, Jee-Hyun ;

Lee, Moon-Kyu .

JOURNAL OF DIABETES, 2016, 8 (03) :405-413

[5]

Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials [J].

Giugliano, Dario ;

Chiodini, Paolo ;

Maiorino, Maria Ida ;

Bellastella, Giuseppe ;

Esposito, Katherine .

ENDOCRINE, 2016, 51 (03) :417-428

[6]

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape) [J].

Vora, J. ;

Cohen, N. ;

Evans, M. ;

Hockey, A. ;

Speight, J. ;

Whately-Smith, C. .

DIABETES OBESITY & METABOLISM, 2015, 17 (12) :1133-1141

[7]

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents [J].

Home, Philip D. ;

Dain, Marie-Paule ;

Freemantle, Nick ;

Kawamori, Ryuzo ;

Pfohl, Martin ;

Brette, Sandrine ;

Pilorget, Valerie ;

Scherbaum, Werner A. ;

Vespasiani, Giacomo ;

Vincent, Maya ;

Balkau, Beverley .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (02) :350-359

[8]

Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial [J].

Jia, Weiping ;

Xiao, Xinhua ;

Ji, Qiuhe ;

Ahn, Kyu-Jeung ;

Chuang, Lee-Ming ;

Bao, Yuqian ;

Pang, Can ;

Chen, Lei ;

Gao, Fei ;

Tu, Yinfang ;

Li, Pengfei ;

Yang, Jun .

LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (04) :254-262

[9]

Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial [J].

Tinahones, F. J. ;

Gross, J. L. ;

Onaca, A. ;

Cleall, S. ;

Rodriguez, A. .

DIABETES OBESITY & METABOLISM, 2014, 16 (10) :963-970

[10]

Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study [J].

Dieuzeide, Guillermo ;

Chuang, Lee-Ming ;

Almaghamsi, Abdulrahman ;

Zilov, Alexey ;

Chen, Jian-Wen ;

Lavalle-Gonzalez, Fernando J. .

PRIMARY CARE DIABETES, 2014, 8 (02) :111-117